因僵硬行翻修全膝关节置换术的患者围手术期疼痛评分与阿片类药物消耗与其他无菌指征翻修者相似
本研究比较因僵硬与因其他无菌指征行翻修全膝关节置换术(rTKA)患者的术后疼痛评分、90天阿片类药物使用及使用时长。纳入337例患者,僵硬组162例,对照组175例。结果显示两组在术后各时间点阿片类药物使用率、疼痛评分、总吗啡毫克当量(MME)、住院期间每小时MME消耗及阿片类药物补充次数均无显著差异,尽管僵硬组术前阿片类药物使用率更高。
要点
- 僵硬组术前阿片类药物使用率显著高于对照组(15.4% vs 5.7%,P=0.003)。
- 两组术后10、28、90天阿片类药物使用率无显著差异(P>0.05)。
- 两组术后6周疼痛评分、总MME、住院每小时MME及补充次数均无显著差异。
核心结论
- 因僵硬行rTKA的患者尽管术前阿片类药物使用率更高,但术后MME、阿片类药物补充次数、停药时间及疼痛评分与对照组相似。
- 鉴于僵硬组90天问卷应答率较低,这些发现需谨慎对待,因最坏情况非应答者分析下90天相似性不成立。
研究设计与样本
- 回顾性队列研究,纳入2018至2022年因僵硬(n=162,48.1%)或无菌性松动/不稳(对照,n=175,51.9%)行rTKA的337例患者。
- 术后10、28、90天进行电话调查评估疼痛和阿片类药物使用,并查阅病历收集人口学、疼痛及吗啡毫克当量(MME)数据。
- 使用卡方检验或Student t检验比较两组各结局。
主要发现
- 僵硬组术前阿片类药物使用率显著高于对照组(15.4% vs 5.7%,P=0.003)。
- 总体阿片类药物使用率在术后10、28、90天分别为84%、49%、12%,两组各时间点均无显著差异(P>0.05)。
- 两组术后6周疼痛评分相似(2.75 vs 2.81;P=0.6),总MME相似(695.2 vs 785;P=0.7),住院每小时MME消耗相似(1.66 vs 1.70;P=0.7),阿片类药物补充次数相似(0.55 vs 0.76;P=0.2)。
临床怎么用
- 可为因僵硬行rTKA的患者提供咨询,告知其术后疼痛和阿片类药物需求与其他无菌指征翻修者相似。
- 尽管僵硬组术前阿片类药物使用率更高,术后阿片类药物消耗和疼痛评分并未更高,可据此设定期望。
局限性
- 僵硬组90天问卷应答率较低,最坏情况非应答者分析下90天相似性不成立,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients undergoing revision total knee arthroplasty (rTKA) for stiffness have inferior clinical outcomes compared to other aseptic indications, but whether they have higher or more prolonged opioid consumption is unclear. This study compared (1) postoperative pain scores, (2) 90-day postoperative opioid use, and (3) duration of opioid use in patients undergoing rTKA for stiffness versus aseptic indications. METHODS: This study included 337 patients who underwent rTKA for stiffness (n = 162, 48.1%) or for aseptic loosening or instability (control; n = 175, 51.9%) from 2018 to 2022. Patients completed a phone survey at 10, 28, and 90 days postoperatively to assess pain and opioid use, and chart review was performed to collect demographic, pain, and morphine milligram equivalents (MMEs) data. Stiffness and control rTKA groups were compared for each outcome using Chi-square or Student's t-tests. RESULTS: Stiff rTKA patients had significantly higher rates of preoperative opioid usage than control patients (15.4 versus 5.7%, P = 0.003). Overall rates of opioid use were 84, 49, and 12% at 10, 28, and 90 days postoperative and did not differ between groups at any timepoint (P > 0.05). Both groups had similar pain scores at 6 weeks postoperatively (2.75 versus 2.81; P = 0.6), similar total MME (695.2 versus 785; P = 0.7), similar inpatient hourly MME consumption (1.66 versus 1.70; P = 0.7), and a similar number of opioid refills (0.55 versus 0.76; P = 0.2). CONCLUSIONS: Patients undergoing rTKA for stiffness had similar MME, opioid refills, time to opioid discontinuation, and pain scores as controls, despite higher preoperative opioid use. Given the stiffness cohort's lower 90-day survey response rate, these findings warrant caution, as the 90-day similarity did not hold under the worst-case nonresponder scenario. This should guide patient counseling and pain management expectations.
引用
- Shin J, Driscoll DA, Selkridge I, et al. Patients Undergoing Revision Total Knee Arthroplasty for Stiffness Have Similar Perioperative Pain Scores and Postoperative Opioid Consumption Compared to Patients Undergoing Revisions for Other Aseptic Indications. J Arthroplasty. 2026. PMID: 42749092. doi:10.1016/j.arth.2026.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。